Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Ghrelin Protects H9c2 Cardiomyocytes From Angiotensin II–induced Apoptosis Through the Endoplasmic Reticulum Stress Pathway

Yang, Chunyan MD*; Wang, Yinan PhD; Liu, Haiyan PhD; Li, Nan MD; Sun, Yang MD; Liu, Zhonghui PhD*,†; Yang, Ping PhD*

Journal of Cardiovascular Pharmacology: May 2012 - Volume 59 - Issue 5 - p 465–471
doi: 10.1097/FJC.0b013e31824a7b60
Original Article

Abstract: Ghrelin, a gastric hormone, exerts cardioprotective function by increasing myocardial contractility and vasodilation. Previous studies have reported that angiotensin II (Ang II) production increased in heart failure, which can induce cardiomyocyte apoptosis. In this study, we investigated the effect of ghrelin on Ang II–induced H9c2 cardiomyocyte apoptosis. The results showed that Ang II inhibited H9c2 cell viability, which was blocked by ghrelin. By annexin V–propidium iodide dual staining and 2′-deoxyuridine 5′-triphosphate nick end-labeling analysis, we found that Ang II induced H9c2 cell apoptosis, whereas coincubation of ghrelin with Ang II significantly reduced H9c2 cell apoptosis induced by Ang II. Simultaneously, the results revealed that ghrelin regulated the Ang II–induced imbalance of Bax and Bcl-2 expression and reduced Ang II–induced caspase-3 expression. Moreover, mRNA expressions of endoplasmic reticulum stress-related molecules GRP78, caspase-12, and C/EBP homologous protein were significantly upregulated by Ang II. However, their expressions were significantly inhibited by ghrelin. In addition, we found that ghrelin markedly inhibited Ang II–induced Ang II type 1 receptor expression. These data suggest that ghrelin may play an antagonistic role in Ang II–induced cardiomyocyte apoptosis via decreasing Ang II type 1 receptor expression and inhibiting the activation of endoplasmic reticulum stress pathway.

*Department of Cardiology, China–Japan Union Hospital, Jilin University

Department of Immunology

Department of Anatomy, Norman Bethune College of Medicine, Jilin University, Changchun, China.

Reprints: Zhonghui Liu, PhD, and Ping Yang, PhD, China-Japan Union Hospital, Jilin University, Changchun 130033, China (e-mail:;

Supported by grants from the Ministry of Science and Technology of China (no. 09C26212203285) and the Project of Science and Technology of Jilin Province (no 201115094).

The authors report no conflict of interest.

Received November 29, 2011

Accepted January 9, 2012

© 2012 Lippincott Williams & Wilkins, Inc.